CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

NCT02827890 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chong Kun Dang Pharmaceutical